| (INR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 153.00B | — |
| Operating expense | — | — |
| Net income | 28.95B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, SUNPHARMA.NS returned +17.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +12.1% |
| 1 year | +17.4% |
| 5 years | +152.7% |
| 10 years | +168.7% |
| All-time high | ₹1,990.50 (Jul 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ₹1,000 in SUNPHARMA.NS would be worth today ›Yes. Sun Pharmaceutical Industries Limited paid 2 dividends over the past 12 months. The most recent was ₹5.00 per share on Jul 7, 2026. The dividend yield is 0.84%.
Sun Pharmaceutical Industries Limited is part of the Healthcare sector.
Sun Pharmaceutical Industries Limited has a market cap of 4.58T INR, based on the latest quote.
